Literature DB >> 18975283

Liver tumors: pediatric population.

Milton J Finegold1, Rachel A Egler, John A Goss, R Paul Guillerman, Saul J Karpen, Rajesh Krishnamurthy, Christine Ann O'Mahony.   

Abstract

Liver tumors in childhood are rare and are typically not detected clinically until they reach a large size and often spread within the organ or metastasize. This can make surgical resection problematic, and almost all of them require extirpation for cure. With very effective chemotherapy for hepatoblastoma and to some extent for sarcomas, many cancers can be shrunk to permit partial hepatectomy, but for most hepatocarcinomas, some of the other malignancies, and even some benign proliferations, their location at the hilum and multiplicity of masses in multiple lobes make transplantation the treatment of choice. Major advances in diagnostic imaging, especially enhanced computed tomography and magnetic resonance imaging, permit a preoperative choice of resection versus transplantation to be achieved in almost all instances, and for the remainder, intraoperative ultrasonography can further help to determine the most desirable approach. The outcome is very much better in the case of hepatoblastoma when transplantation is a primary modality rather than following unsuccessful attempts at resection. In this review, transplantation for liver tumors in children is considered from all aspects, including the importance of screening for tumors whenever possible to avoid the need for transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18975283     DOI: 10.1002/lt.21654

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  18 in total

1.  Current therapeutic strategies for childhood hepatic malignant tumors.

Authors:  Eiso Hiyama
Journal:  Int J Clin Oncol       Date:  2013-09-21       Impact factor: 3.402

Review 2.  Targeted MRI contrast agents for pediatric hepatobiliary disease.

Authors:  Jesse L Courtier; Emily R Perito; Sue Rhee; Patrika Tsai; Melvin B Heyman; John D MacKenzie
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-04       Impact factor: 2.839

3.  Hepatic hemangioendothelioma presenting as sudden unexpected death in infancy: a case report.

Authors:  Johan Dempers; Shabbir Ahmed Wadee; Theonia Boyd; Colleen Wright; Hein J Odendaal; Mary Ann Sens
Journal:  Pediatr Dev Pathol       Date:  2010-05-13

4.  Infantile hepatic hemangioendothelioma: a clinicopathologic study in a Chinese population.

Authors:  Zhang Zhang; Hui-Jiao Chen; Wen-Juan Yang; Hong Bu; Bing Wei; Xiao-Yu Long; Jing Fu; Rui Zhang; Yun-Bi Ni; Hong-Ying Zhang
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

5.  MYBL2 accelerates epithelial-mesenchymal transition and hepatoblastoma metastasis via the Smad/SNAI1 pathway.

Authors:  Meng Wei; Ran Yang; Mujie Ye; Yong Zhan; Baihui Liu; Lingdu Meng; Lulu Xie; Min Du; Junfeng Wang; Runnan Gao; Deqian Chen; Rui Dong; Kuiran Dong
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

6.  Metastatic hepatocellular carcinoma in a juvenile rhesus macaque (Macaca mulatta).

Authors:  Steven T Laing; Marie J Lemoy; Rebecca L Sammak; Ross P Tarara
Journal:  Comp Med       Date:  2013-10       Impact factor: 0.982

7.  Predictors of survival and incidence of hepatoblastoma in the paediatric population.

Authors:  Bassan J Allan; Punam P Parikh; Sofia Diaz; Eduardo A Perez; Holly L Neville; Juan E Sola
Journal:  HPB (Oxford)       Date:  2013-04-22       Impact factor: 3.647

8.  Surgical management of giant liver tumor involving the hepatic hilum of children.

Authors:  Qian Dong; Buxian Jiang; Yun Lu; Hong Zhang; Zhong Jiang; Hongting Lu; Chuanmin Yang; Jing Zhao; Xiwei Hao
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

Review 9.  Infantile hepatic hemangioma: current state of the art, controversies, and perspectives.

Authors:  Nikolaos Zavras; Anastasia Dimopoulou; Nikolaos Machairas; Anna Paspala; George Vaos
Journal:  Eur J Pediatr       Date:  2019-11-22       Impact factor: 3.183

10.  AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.

Authors:  Lyudmyla G Glushakova; Matthew J Lisankie; Evgeniy B Eruslanov; Carolyn Ojano-Dirain; Irene Zolotukhin; Chen Liu; Arun Srivastava; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2009-06-23       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.